Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease

Alzheimer's Research and Therapy

Volumn 3, Issue 6, 2011, Pages

  Frank, Lori ^a   Lenderking, William R ^b   Howard, Kellee ^b   Cantillon, Marc ^c  

^a PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c Wellness Managements LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; EXECUTIVE FUNCTION; HUMAN; INTROSPECTION; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; SELF REPORT;

EID: 83155173896     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt97     Document Type: Review

References (129)

1. Guidance for Industry on Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health, Health Qual Life Outcomes 2006 4 79 17034633
2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH, Alzheimers Dement 2011 7 270 279 10.1016/j.jalz.2011.03.008 21514249
3. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH, Alzheimers Dement 2011 7 280 292 10.1016/j.jalz.2011.03. 003 21514248
4. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK, Neurology 2009 72 1555 1561 10.1212/01.wnl. 0000344650.95823.03 19176895
5. American Psychiatric Association. Task Force on DSM-IV, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. International Version with ICD-10 Codes Washington, DC: American Psychiatric Association 4 1995
6. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P, Lancet Neurol 2007 6 734 746 10.1016/S1474-4422(07)70178-3 17616482 (Pubitemid 47058377)
7. Shifts in thinking about dementia. Hachinski V, JAMA 2008 300 2172 2173 10.1001/jama.2008.525 19001628
8. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC, J Intern Med 2004 256 240 246 10.1111/j.1365-2796.2004.01380.x 15324367 (Pubitemid 39222993)
9. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST, Neurology 2001 56 1133 1142 11342677
10. Experience and perspectives of caregivers of spouse with mild cognitive impairment. Lu YF, Haase JE, Curr Alzheimer Res 2009 6 384 391 10.2174/156720509788929309 19689238
11. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Robert P, Onyike CU, Leentjens AF, Dujardin K, Aalten P, Starkstein S, Verhey FR, Yessavage J, Clement JP, Drapier D, Bayle F, Benoit M, Boyer P, Lorca PM, Thibaut F, Gauthier S, Grossberg G, Vellas B, Byrne J, Eur Psychiatry 2009 24 98 104 10.1016/j.eurpsy.2008.09.001 19201579
12. 'I don't do like I used to do': a grounded theory approach to conceptualising awareness in people with moderate to severe dementia living in long-term care. Clare L, Rowlands J, Bruce E, Surr C, Downs M, Soc Sci Med 2008 66 2366 2377 10.1016/j.socscimed.2008.01.045 18325650 (Pubitemid 351608732)
13. Cognitive, extrapyramidal, and magnetic resonance imaging predictors of functional impairment in nondemented older community dwellers: the Sydney Older Person Study. Bennett HP, Piguet O, Grayson DA, Creasey H, Waite LM, Lye T, Corbett AJ, Hayes M, Broe GA, Halliday GM, J Am Geriatr Soc 2006 54 3 10 10.1111/j.1532-5415.2005.00532.x 16420192
14. Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment. Frank L, Flynn JA, Kleinman L, Margolis MK, Matza LS, Beck C, Bowman L, Int Psychogeriatr 2006 18 135 149 10.1017/S1041610205002887 16403248
15. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Farias ST, Mungas D, Jagust W, Int J Geriatr Psychiatry 2005 20 827 834 10.1002/gps.1367 16116577 (Pubitemid 41358673)
16. Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight? Vogel A, Stokholm J, Gade A, Andersen BB, Hejl AM, Waldemar G, Dement Geriatr Cogn Disord 2004 17 181 187 10.1159/000076354 14739542 (Pubitemid 38339745)
17. Caregivers' judgments of the functional abilities of the Alzheimer's disease patient: impact of caregivers' depression and perceived burden. Arguelles S, Loewenstein DA, Eisdorfer C, Arguelles T, J Geriatr Psychiatry Neurol 2001 14 91 98 10.1177/089198870101400209 11419574 (Pubitemid 32538658)
18. Revising the definition of Alzheimer's disease: a new lexicon. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P, Lancet Neurol 2010 9 1118 1127 10.1016/S1474-4422(10) 70223-4 20934914
19. MULTIDISCIPLINARY studies of illness in aged persons; a new classification of functional status in activities of daily living. Benjamin Rose Hospital Staff, J Chronic Dis 1959 9 1 55 62 10.1016/0021-9681(59)90137-7 13611014
20. Studies of Illness in the Aged. The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW, JAMA 1963 185 914 919 10.1001/jama.1963.03060120024016 14044222
21. Assessment of older people: self-maintaining and instrumental activities of daily living. Lawton MP, Brody EM, Gerontologist 1969 9 179 186 10.1093/geront/9.3-Part-1.179 5349366
22. Using functional status to assess treatment outcomes. Leidy NK, Chest 1994 106 1645 1646 10.1378/chest.106.6.1645 7988177 (Pubitemid 24375119)
23. Adherence to medication in patients with dementia: predictors and strategies for improvement. Arlt S, Lindner R, Rosler A, von Renteln-Kruse W, Drugs Aging 2008 25 1033 1047 10.2165/0002512-200825120-00005 19021302
24. Awareness in dementia: a review of clinical correlates. Aalten P, van Valen E, Clare L, Kenny G, Verhey F, Aging Ment Health 2005 9 414 422 10.1080/13607860500143075 16024400 (Pubitemid 41097714)
25. Navigating patients and caregivers through the course of Alzheimer's disease. Aupperle PM, J Clin Psychiatry 2006 67 Suppl 3 8 14 quiz 23 17029490
26. Donepezil for mild cognitive impairment. Birks J, Flicker L, Cochrane Database Syst Rev 2006 3 D006104 16856114
27. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease. Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A, Health Technol Assess 2006 10 ii iv ix-xi, 1-160 17134598
28. Trazodone for agitation in dementia. Martinon-Torres G, Fioravanti M, Grimley EJ, Cochrane Database Syst Rev 2004 4 D004990 15495135
29. A European consensus on outcome measures for psychosocial intervention research in dementia care. Moniz-Cook E, Vernooij-Dassen M, Woods R, Verhey F, Chattat R, De Vugt M, Mountain G, O'Connell M, Harrison J, Vasse E, Dröes RM, Orrell M, INTERDEM group, Aging Ment Health 2008 12 14 29 10.1080/13607860801919850 18297476 (Pubitemid 351302403)
30. Disease staging and milestones. Rabheru K, Can J Neurol Sci 2007 34 Suppl 1 62 66 17469685
31. Higher-level hand motor function in aging and (preclinical) dementia: its relationship with (instrumental) activities of daily life - a mini-review. Scherder E, Dekker W, Eggermont L, Gerontology 2008 54 333 341 10.1159/000168203 18997468
32. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. Sikkes SA, de Lange-de Klerk ES, Pijnenburg YA, Scheltens P, Uitdehaag BM, J Neurol Neurosurg Psychiatry 2009 80 7 12 10.1136/jnnp.2008.155838 19091706
33. Effects of cognitive training interventions with older adults: a randomized controlled trial. Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, Morris JN, Rebok GW, Smith DM, Tennstedt SL, Unverzagt FW, Willis SL, Advanced Cognitive Training for Independent and Vital Elderly Study Group, JAMA 2002 288 2271 2281 10.1001/jama.288.18.2271 12425704 (Pubitemid 35291757)
34. Functional abilities in older adults with mild cognitive impairment. Burton CL, Strauss E, Bunce D, Hunter MA, Hultsch DF, Gerontology 2009 55 570 581 10.1159/000228918 19602873
35. Significance of behavioral pathology on functional performance in individuals with Alzheimer's disease and related dementias. Cidboy EL, Am J Alzheimers Dis Other Demen 2004 19 279 289 10.1177/153331750401900505 15553984 (Pubitemid 39382857)
36. Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scales. Demers L, Oremus M, Perrault A, Champoux N, Wolfson C, J Geriatr Psychiatry Neurol 2000 13 170 180 10.1177/089198870001300402 11128057 (Pubitemid 32055166)
37. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Blessed G, Tomlinson BE, Roth M, Br J Psychiatry 1968 114 797 811 10.1192/bjp.114.512.797 5662937
38. The blessed dementia scale as a screening test for dementia. Erkinjuntti T, Hokkanen L, Sulkava R, Palo J, Int J Geratr Psychiatry 1988 3 267 273 10.1002/gps.930030406 (Pubitemid 19009818)
39. Assessing patient dependence in Alzheimer's disease. Stern Y, Albert SM, Sano M, Richards M, Miller L, Folstein M, Albert M, Bylsma FW, Lafleche G, J Gerontol 1994 49 216 222 8056940
40. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Gelinas I, Gauthier L, McIntyre M, Gauthier S, Am J Occup Ther 1999 53 471 481 10500855
41. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Gelinas I, Gauthier L, McIntyre M, Gauthier S, Am J Occup Ther 1999 53 5 471 481 10500855
42. The interview for deterioration in daily living activities in dementia: agreement between primary and secondary caregivers. Teunisse S, Derix MM, Int Psychogeriatr 1997 9 Suppl 1 155 162 9309488 (Pubitemid 28045354)
43. Assessing the severity of dementia. Patient and caregiver. Teunisse S, Derix MM, van Crevel H, Arch Neurol 1991 48 274 277 10.1001/archneur.1991. 00530150042015 2001184
44. Measurement of quality-of-life changes in patients with Alzheimer's disease. DeJong R, Osterlund OW, Roy GW, Clin Ther 1989 11 545 554 2776169 (Pubitemid 19202105)
45. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S, Alzheimer Dis Assoc Disord 1997 11 Suppl 2 33 39 9236950
46. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD, Alzheimer Dis Assoc Disord 2006 20 152 169 10.1097/01.wad.0000213873. 25053.2b 17135809 (Pubitemid 44900699)
47. Measurement of functional activities in older adults in the community. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S, J Gerontol 1982 37 323 329 7069156 (Pubitemid 12117513)
48. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials. Cummings JL, Raman R, Ernstrom K, Salmon D, Ferris SH, Alzheimer Dis Assoc Disord 2006 20 147 151 10.1097/01.wad.0000213872.17429.0f 17135808 (Pubitemid 44900698)
49. ADCS Prevention Instrument Project: overview and initial results. Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ, Alzheimer Dis Assoc Disord 2006 20 109 123 10.1097/01.wad.0000213870.40300.21 17135805 (Pubitemid 44900695)
50. ADCS Prevention Instrument Project: quality of life assessment (QOL). Patterson MB, Whitehouse PJ, Edland SD, Sami SA, Sano M, Smyth K, Weiner MF, Alzheimer Dis Assoc Disord 2006 20 179 190 10.1097/01.wad.0000213874.25053.e5 17135811 (Pubitemid 44900701)
51. The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Feldman H, Sauter A, Donald A, Gelinas I, Gauthier S, Torfs K, Parys W, Mehnert A, Alzheimer Dis Assoc Disord 2001 15 89 95 10.1097/00002093-200104000-00008 11391090 (Pubitemid 32525447)
52. Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living. Gelinas I, Gauthier S, Cyrus PA, J Geriatr Psychiatry Neurol 2000 13 9 16 10.1177/089198870001300102 10753002 (Pubitemid 30224003)
53. Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the Sunnybrook dementia cohort. Behl P, Lanctot KL, Streiner DL, Guimont I, Black SE, Curr Alzheiner Res 2006 3 2 147 156 10.2174/156720506776383031
54. ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI). Walsh SP, Raman R, Jones KB, Aisen PS, Alzheimer Dis Assoc Disord 2006 20 170 178 10.1097/01.wad.0000213879.55547.57 17135810 (Pubitemid 44900700)
55. Metamemory monitoring in mild cognitive impairment: Evidence of a less accurate episodic feeling-of-knowing. Perrotin A, Belleville S, Isingrini M, Neuropsychologia 2007 45 2811 2826 10.1016/j.neuropsychologia.2007.05.003 17597165 (Pubitemid 47176590)
56. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. Michon A, Deweer B, Pillon B, Agid Y, Dubois B, J Neurol Neurosurg Psychiatry 1994 57 805 809 10.1136/jnnp.57.7.805 8021665 (Pubitemid 24214960)
57. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Griffith HR, Belue K, Sicola A, Krzywanski S, Zamrini E, Harrell L, Marson DC, Neurology 2003 60 449 457 12578926 (Pubitemid 36188241)
58. Assessing financial capacity in patients with Alzheimer disease: A conceptual model and prototype instrument. Marson DC, Sawrie SM, Snyder S, McInturff B, Stalvey T, Boothe A, Aldridge T, Chatterjee A, Harrell LE, Arch Neurol 2000 57 877 884 10.1001/archneur.57.6.877 10867786 (Pubitemid 30397191)
59. Deficits in facial emotion processing in mild cognitive impairment. Teng E, Lu PH, Cummings JL, Dement Geriatr Cogn Disord 2007 23 271 279 10.1159/000100829 17351319 (Pubitemid 46496815)
60. Spatial cognition and the human navigation network in AD and MCI. DeIpolyi AR, Rankin KP, Mucke L, Miller BL, Gorno-Tempini ML, Neurology 2007 69 986 997 10.1212/01.wnl.0000271376.19515.c6 17785667 (Pubitemid 47366052)
61. Cognitive correlates of financial abilities in mild cognitive impairment. Okonkwo OC, Wadley VG, Griffith HR, Ball K, Marson DC, J Am Geriatr Soc 2006 54 1745 1750 10.1111/j.1532-5415.2006.00916.x 17087703 (Pubitemid 44665215)
62. Executive control functions in degenerative dementias: a comparative review. Duke LM, Kaszniak AW, Neuropsychol Rev 2000 10 75 99 10.1023/A:1009096603879 10937917 (Pubitemid 30480340)
63. Declining executive control in normal aging predicts change in functional status: the Freedom House Study. Royall DR, Palmer R, Chiodo LK, Polk MJ, J Am Geriatr Soc 2004 52 346 352 10.1111/j.1532-5415.2004.52104.x 14962147 (Pubitemid 38339513)
64. The measurement of everyday cognition (ECog): scale development and psychometric properties. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, Decarli C, Neuropsychology 2008 22 531 544 18590364 (Pubitemid 351992899)
65. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests. Farias ST, Harrell E, Neumann C, Houtz A, Arch Clin Neuropsychol 2003 18 655 672 14591439 (Pubitemid 36945503)
66. Neuropsychological predictors of everyday memory and everyday functioning in patients with mild Alzheimer's disease. Cahn-Weiner DA, Ready RE, Malloy PF, J Geriatr Psychiatry Neurol 2003 16 84 89 10.1177/0891988703016002004 12801157 (Pubitemid 37409035)
67. Cognitive predictors of everyday functioning in older adults: results from the ACTIVE Cognitive Intervention trial. Gross AL, Rebok GW, Unverzagt FW, Willis SL, Brandt J, J Gerontol B Psychol Sci Soc Sci 2011 66 557 566 21558167
68. Behavior rating inventory of executive function. Gioia GA, Isquith PK, Guy SC, Kenworthy L, Child Neuropsychol 2000 6 235 238 10.1076/chin.6.3.235.3152 11419452
69. Roth RM, Isquith PK, Gioia GA, Behavioral Rating Inventory of Executive Function-Adult Version Lutz, FL: Psychological Assessment Resources, Inc 2005
70. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Ready RE, Ott BR, Grace J, Cahn-Weiner DA, Am J Geriatr Psychiatry 2003 11 222 228 12611752 (Pubitemid 36254196)
71. Grace J, Malloy P, Frontal Systems Behavior Scale (FrSBe): Professional Manual Lutz, FL: Psychological Assessment Resources 2001
72. Self-and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints. Rabin LA, Roth RM, Isquith PK, Wishart HA, Nutter-Upham KE, Pare N, Flashman LA, Saykin AJ, Arch Clin Neuropsychol 2006 21 721 732 10.1016/j.acn.2006.08.004 16979868 (Pubitemid 44635116)
73. Provisional diagnostic criteria for depression of Alzheimer disease. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Krishnan KR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD, Am J Geriatr Psychiatry 2002 10 125 128 11925273 (Pubitemid 34685625)
74. Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Teng E, Ringman JM, Ross LK, Mulnard RA, Dick MB, Bartzokis G, Davies HD, Galasko D, Hewett L, Mungas D, Reed BR, Schneider LS, Segal-Gidan F, Yaffe K, Cummings JL, Alzheimer's Disease Research Centers of California-Depression in Alzheimer's Disease Investigators, Am J Geriatr Psychiatry 2008 16 469 477 10.1097/JGP.0b013e318165dbae 18515691
75. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL, Neurology 2009 72 2115 2121 10.1212/WNL.0b013e3181aa52d3 19528519
76. Behavioural and psychological symptoms in the older population without dementia - relationship with socio-demographics, health and cognition. van der Linde R, Stephan BC, Matthews FE, Brayne C, Savva GM, BMC Geriatr 2010 10 87 10.1186/1471-2318-10-87 21118498
77. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Apostolova LG, Cummings JL, Dement Geriatr Cogn Disord 2008 25 115 126 10.1159/000112509 18087152 (Pubitemid 351196123)
78. Schipper H, Clinch JJ, Olweny CL, Quality of Life Studies: Definitions and Conceptual Issues Philadelphia: Lippincott-Raven 2 1996
79. Ware JE, Methodological Considerations in the Selection of Health Status Assessment Procedures Greenwich, CT: La Jacq 1984
80. A review of quality of life instruments used in dementia. Ettema TP, Droes RM, de Lange J, Mellenbergh GJ, Ribbe MW, Qual Life Res 2005 14 675 686 10.1007/s11136-004-1258-0 16022061 (Pubitemid 40576854)
81. Quality of life in Alzheimer's disease: patient and caregiver reports. Logsdon RG, Gibbons LE, McCurry SM, Teri L, J Mental Health Aging 1999 5 21 32 (Pubitemid 29235115)
82. Quality of life in older Belgian people: comparison between people with dementia, mild cognitive impairment, and controls. Missotten P, Squelard G, Ylieff M, Di Notte D, Paquay L, De Lepeleire J, Fontaine O, Int J Geriatr Psychiatry 2008 23 1103 1109 10.1002/gps.1981 18213606
83. Quality of life of the community-based patients with mild cognitive impairment. Muangpaisan W, Assantachai P, Intalapaporn S, Pisansalakij D, Geriatr Gerontol Int 2008 8 80 85 10.1111/j.1447-0594.2008.00452.x 18713159
84. The patient with dementia, the caregiver and the doctor: cognition, depression and quality of life from three perspectives. Arlt S, Hornung J, Eichenlaub M, Jahn H, Bullinger M, Petersen C, Int J Geriatr Psychiatry 2008 23 604 610 10.1002/gps.1946 18008392 (Pubitemid 351943845)
85. Assessment of quality of life as outcome in dementia and MCI intervention trials: a systematic review. Scholzel-Dorenbos CJ, van der Steen MJ, Engels LK, Olde Rikkert MG, Alzheimer Dis Assoc Disord 2007 21 172 178 10.1097/WAD.0b013e318047df4c 17545745 (Pubitemid 46878981)
86. Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer's disease - further evidence for the impact of anosognosia and global cognitive impairment. Berwig M, Leicht H, Gertz HJ, J Nutr Health Aging 2009 13 226 230 10.1007/s12603-009-0063-4 19262958
87. Impaired insight in Alzheimer's disease. Mangone CA, Hier DB, Gorelick PB, Ganellen RJ, Langenberg P, Boarman R, Dollear WC, J Geriatr Psychiatry Neurol 1991 4 189 193 10.1177/089198879100400402 1789906
88. Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD Clinical Investigators. Consortium to Establish a Registry for Alzheimer's Disease. McDaniel KD, Edland SD, Heyman A, Alzheimer Dis Assoc Disord 1995 9 101 104 10.1097/00002093-199509020-00007 7662321
89. Two domains of anosognosia in Alzheimer's disease. Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R, J Neurol Neurosurg Psychiatry 1996 61 485 490 10.1136/jnnp.61.5.485 8937343 (Pubitemid 26394906)
90. Insight in Alzheimer's patients: results of a longitudinal study using three assessment methods. Arkin S, Mahendra N, Am J Alzheimers Dis Other Demen 2001 16 211 224 10.1177/153331750101600401 11501343 (Pubitemid 32729948)
91. Cognitive complaint in mild cognitive impairment and Alzheimer's disease. Clement F, Belleville S, Gauthier S, J Int Neuropsychol Soc 2008 14 222 232 18282320 (Pubitemid 351280001)
92. Insight into memory deficits. Markova IS, Berrios GE, Memory Disorders in Psychiatric Practice New York: Cambridge University Press, Berrios GE, Hodges JR, 2000 204 233
93. Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment. Kalbe E, Salmon E, Perani D, Holthoff V, Sorbi S, Elsner A, Weisenbach S, Brand M, Lenz O, Kessler J, Luedecke S, Ortelli P, Herholz K, Dement Geriatr Cogn Disord 2005 19 349 356 10.1159/000084704 15802909 (Pubitemid 40663331)
94. Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in selfappraisal. Ries ML, Jabbar BM, Schmitz TW, Trivedi MA, Gleason CE, Carlsson CM, Rowley HA, Asthana S, Johnson SC, J Int Neuropsychol Soc 2007 13 450 461 17445294 (Pubitemid 47307485)
95. Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: a systematic review. Roberts JL, Clare L, Woods RT, Dement Geriatr Cogn Disord 2009 28 95 109 10.1159/000234911 19684399
96. Objective metamemory testing captures awareness of deficit in Alzheimer's disease. Cosentino S, Metcalfe J, Butterfield B, Stern Y, Cortex 2007 43 1004 1019 10.1016/S0010-9452(08)70697-X 17941356 (Pubitemid 47517044)
97. The impact of caregiver executive skills on reports of patient functioning. Dassel KB, Schmitt FA, Gerontologist 2008 48 781 792 10.1093/geront/48.6.781 19139251
98. Executive functioning and observed versus self reported measures of functional ability. Mitchell M, Miller LS, Clin Neuropsychol 2008 22 471 479 10.1080/13854040701336436 17853131 (Pubitemid 351892462)
99. The relationship between quality of life, MMSE, and the IADL in patients with Alzheimer' s disease. Wlodarczyk JH, Brodaty H, Hawthorne G, Arch Gerontol Geriatr 2004 39 25 33 10.1016/j.archger.2003.12.004 15158578 (Pubitemid 38670389)
100. Awareness of cognitive deficits in older adults with cognitive- impairment-no-dementia (CIND): comparison with informant report. Greenop KR, Xiao J, Almeida OP, Flicker L, Beer C, Foster JK, van Bockxmeer FM, Lautenschlager NT, Alzheimer Dis Assoc Disord 2011 25 24 33 10.1097/WAD. 0b013e3181f81094 20921874
101. Insight in dementia: when does it occur? Evidence for a nonlinear relationship between insight and cognitive status. Zanetti O, Vallotti B, Frisoni GB, Geroldi C, Bianchetti A, Pasqualetti P, Trabucchi M, J Gerontol B Psychol Sci Soc Sci 1999 54 100 106 10097772
102. Relationship between cognition and awareness of deficit in mild cognitive impairment. Tremont G, Alosco ML, Int J Geriatr Psychiatry 2011 26 299 306 10.1002/gps.2529 20623477
103. Impaired awareness of deficits in Alzheimer disease. Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS, Alzheimer Dis Assoc Disord 1996 10 68 76 10.1097/00002093-199601020-00003 8727167 (Pubitemid 26168437)
104. Kleinman L, Frank L, Flynn JA, Matza L, Bowman L, Comparison of Informant and Neuropsychological Ratings of Cognitive Impairment New York, NY: American Psychiatric Association 2004
105. Awareness of functional difficulties in mild cognitive impairment: a multidomain assessment approach. Okonkwo OC, Griffith HR, Vance DE, Marson DC, Ball KK, Wadley VG, J Am Geriatr Soc 2009 57 978 984 10.1111/j.1532-5415.2009. 02261.x 19467146
106. Self awareness and personality change in dementia. Rankin KP, Baldwin E, Pace-Savitsky C, Kramer JH, Miller BL, J Neurol Neurosurg Psychiatry 2005 76 632 639 10.1136/jnnp.2004.042879 15834018 (Pubitemid 40569671)
107. Self-awareness and self-monitoring of cognitive and behavioral deficits in behavioral variant frontotemporal dementia, primary progressive aphasia and probable Alzheimer's disease. Banks S, Weintraub S, Brain Cogn 2008 67 58 68 10.1016/j.bandc.2007.11.004 18194832
108. Subjective memory beliefs and cognitive performance in normal and mildly impaired older adults. Cook S, Marsiske M, Aging Ment Health 2006 10 413 423 10.1080/13607860600638487 16798634 (Pubitemid 43977376)
109. The premild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease. Reisberg B, Prichep L, Mosconi L, John ER, Glodzik-Sobanska L, Boksay I, Monteiro I, Torossian C, Vedvyas A, Ashraf N, Jamil IA, de Leon MJ, Alzheimers Dement 2008 4 98 S108 10.1016/j.jalz.2007.11. 017 18632010
110. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Reisberg B, Gauthier S, Int Psychogeriatr 2008 20 1 16 18072981 (Pubitemid 350256071)
111. Introduction to revised criteria for the diagnosis of Alzheimer's disease: National Institute on Aging and the Alzheimer's Association workgroup. Jack CR Jr, Albert M, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, Thies B, Phelps CH, Alzheimers Dement 2011 7 257 262 10.1016/j.jalz.2011.03.004 21514247
112. Changes in neuropsychiatric symptoms as outcome measures in clinical trials with cholinergic therapies for Alzheimer disease. Cummings JL, Alzheimer Dis Assoc Disord 1997 11 Suppl 4 1 9 9348421
113. Weight loss as a predictor of dementia and Alzheimer's disease? Nourhashemi F, Vellas B, Expert Rev Neurother 2008 8 691 693 10.1586/14737175.8.5.691 18457525 (Pubitemid 351656820)
114. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. Gillette Guyonnet S, Abellan Van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, Bonnefoy M, Brocker P, Constans T, Ferry M, Ghisolfi-Marque A, Girard L, Gonthier R, Guerin O, Hervy MP, Jouanny P, Laurain MC, Lechowski L, Nourhashemi F, Raynaud-Simon A, Ritz P, Roche J, Rolland Y, Salva T, Vellas B, International Academy on Nutrition and Aging Expert Group, J Nutr Health Aging 2007 11 38 48 17315079 (Pubitemid 46424268)
115. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, Cantet C, Ousset PJ, Grandjean H, J Nutr Health Aging 2005 9 75 80 15791349 (Pubitemid 40478062)
116. Weight loss in Alzheimer disease. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezinski I, Ousset PJ, Riviere D, Albarede JL, Vellas B, Am J Clin Nutr 2000 71 637S 642S 10681272 (Pubitemid 30061249)
117. Dysphagia in Alzheimer disease: a review. Chouinard J, J Nutr Health Aging 2000 4 214 217 11115803 (Pubitemid 32044694)
118. Eating changes in mild-stage Alzheimer's disease: a pilot study. Priefer BA, Robbins J, Dysphagia 1997 12 212 221 10.1007/PL00009539 9294942 (Pubitemid 27434440)
119. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H, Neurobiol Aging 2008 29 693 706 10.1016/j.neurobiolaging.2006.11.014 17207898 (Pubitemid 351410525)
120. A transcultural study of agitation in dementia. Fuh JL, Mega MS, Binetti G, Wang SJ, Magni E, Cummings JL, J Geriatr Psychiatry Neurol 2002 15 171 174 12230087 (Pubitemid 35001106)
121. Neuropsychiatric symptoms of Alzheimer's disease differ in Chinese and American patients. Chow TW, Liu CK, Fuh JL, Leung VP, Tai CT, Chen LW, Wang SJ, Chiu HF, Lam LC, Chen QL, Cummings JL, Int J Geriatr Psychiatry 2002 17 22 28 10.1002/gps.509 11802226 (Pubitemid 34121092)
122. The ICTUS Study: A Prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Reynish E, Cortes F, Andrieu S, Cantet C, Olde Rikkert M, Melis R, Froelich L, Frisoni GB, Jönsson L, Visser PJ, Ousset PJ, Vellas B, ICTUS Study Group, Neuroepidemiology 2007 29 29 38 10.1159/000108915 17898521 (Pubitemid 350191415)
123. Functional evaluation distinguishes MCI patients from healthy elderly people - the ADCS/MCI/ADL scale. Pedrosa H, De Sa A, Guerreiro M, Maroco J, Simoes MR, Galasko D, de Mendonca A, J Nutr Health Aging 2010 14 703 709 10.1007/s12603-010-0102-1 20922349
124. A survey of Multiple Sclerosis. Part I: Perceived cognitive problems and compensory stratey use. Sullivan MJL, Edgley K, Dehoux E, Can J Rehab 1990 4 99 105
125. Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire. Locke DE, Dassel KB, Hall G, Baxter LC, Woodruff BK, Hoffman Snyder C, Miller BL, Caselli RJ, Dement Geriatr Cogn Disord 2009 27 260 272 10.1159/000203890 19246911
126. Self assessment of cognitive deficits. McNair D, Kahn R, Assessment in Geriatric Psychopharmacology New Canaan, CT: Mark Powley, Crook T, Ferris A, Baltus R, 1983 137 143
127. Cognitive reserve and anosognosia in questionable and mild dementia. Spitznagel MB, Tremont G, Arch Clin Neuropsychol 2005 20 505 515 10.1016/j.acn.2004.11.003 15896563 (Pubitemid 40719553)
128. A multiphasic personality schedule (Minnesota): I. Construction of the schedule. Hathaway SR, McKinley JC, J Psychology 1940 10 249 254 10.1080/00223980.1940.9917000
129. Frontal behavioral syndromes and functional status in probable Alzheimer